B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Topotecan

300 PubMed studies analyzed · 25 RCTs · Evidence Score: 47.9

Research Domains

Topotecan has been studied across 13 research domains including 🔬 Oncology, 🧬 Hormones, 🫁 Liver & Detox, 👁️ Vision & Eye, ⏳ Longevity & Aging. The primary research focus is 🔬 Oncology with 74% of studies addressing this area.

Loading evidence profile...

This evidence profile for Topotecan is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.